Early response as assessed by anatomic imaging does not predict failure-free survival among patients with Group III rhabdomyosarcoma: A report from the Children’s Oncology Group-Reference-Cited by-同舟云学术

Early response as assessed by anatomic imaging does not predict failure-free survival among patients with Group III rhabdomyosarcoma: A report from the Children’s Oncology Group

Published:2014-03 Issue:4 Volume:50 Page:816-823
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Rosenberg Abby R.,Anderson James R.,Lyden Elizabeth,Rodeberg David A.,Wolden Suzanne L.,Kao Simon C.,Parham David M.,Arndt Carola,Hawkins Douglas S.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. Rhabdomyosarcoma: review of the Children’s Oncology Group (COG) soft-tissue sarcoma committee experience and rationale for current COG studies;Malempati;Pediatr Blood Cancer,2012

2. Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children’s Cancer Study Group. Pediatric Oncology Group;Lawrence;Cancer,1997

3. The third Intergroup Rhabdomyosarcoma Study;Crist;J Clin Oncol,1995

4. Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification – an Intergroup Rhabdomyosarcoma Study;Newton;Cancer,1995

5. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease;Crist;J Clin Oncol,2001

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Prognostic Significance of Early Tumor Volume Change in Rhabdomyosarcoma;Advances in Radiation Oncology;2024-08

2. Roadmap for the next generation of Children’s Oncology Group rhabdomyosarcoma trials;Cancer;2024-06-28

3. Event‐free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group;Pediatric Blood & Cancer;2024-04-16

4. Frontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG);Cancers;2024-02-29

5. The Prognostic Significance of Early Tumor Volume Change in Rhabdomyosarcoma;2024